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Introduction
Preeclampsia is a devastating disease of pregnancy affecting 5-7% 
of all pregnancies in the US [1,2]. While preeclampsia remains a 
significant contributor to maternal deaths, it is also a great cause of 
perinatal morbidity. For many patients, this disease is associated with 
devastating effects underscored by severe maternal morbidity. While 
the manifestations of preeclampsia do not appear until 20 weeks 
gestation, the disease process is hypothesized to begin at implantation 
[3-7]. During a normal pregnancy the invading trophoblasts remodel 
the uterine spiral arterioles creating a low resistance system allowing 
for increased blood volume delivery. When trophoblastic invasion is 
shallow, the arteriolar remodeling is blunted and the vascular resistance 
remains high, oxygenated blood flow is decreased and placental 
ischemia results. In addition to the fetal effects of impaired growth, 
placental ischemia has been shown to result in the production of 
vasoactive peptides and inflammatory cytokines [8-10]. These findings 
have been verified in the Reduced Uterine Perfusion Pressure (RUPP) 
model of preeclampsia, where pregnant rats that have surgically 
induced placental ischemia have elevated levels of circulating TNF-α, 
IL-6, IL-17, and sFlt-1 [8-13]. 
Newer research has begun to elucidate the role of the immune 
system in the pathogenesis of preeclampsia [14-21]. Many believe that 
partial failure of the maternal immune tolerance mechanisms precedes 
the development of placental oxidative stress and ischemia, both of 
which are major players in the pathophysiology of preeclampsia. This 
maternal immune tolerance involves crucial interactions between 
regulatory CD4+ T cells and uterine natural killer cells recognizing and 
accepting the fetal antigens and facilitating placental growth. Partial 
failure of this crucial step leads to poor placentation and dysfunctional 
placental perfusion and chronic immune activation originating in the 
placenta. Importantly, analysis of circulating blood collected from 
preeclamptic women has demonstrated a decrease in the proportion of 
circulating T regulatory cells [4,18]. Again, these findings are replicated 
in an animal model of preeclampsia which utilizes the RUPP procedure 
which revealed that pregnant RUPP rats had a 47% decrease in FoxP3+ 
T regulatory cells in the peripheral circulation when compared to NP 
rats. This represents a shift from the normal anti-inflammatory Th2 
state of pregnancy to the pro-inflammatory Th1 state [4,15,20]. 
While preeclampsia has not historically been classified as an 
autoimmune disorder, this shift in humoral immunity and production 
of autoantibodies certainly indicates that perhaps it should. In fact, T 
helper 17 cells, which have been known to upregulate in autoimmune 
disorders including lupus, psoriasis, and multiple sclerosis, are 
increased in preeclamptic women [4,15,18-20]. With a loss of T 
regulatory cells, the body loses the normal protection it has against 
the creation of autoantibodies. One of the most promising findings 
indicating the importance of T cells has been the discovery of a class 
3 IgG molecule that stimulates the angiotensin type I receptor [17]. 
This agonistic autoantibody to the AT1receptor (AT1-AA) has been 
isolated from the sera of preeclamptic, but not normal pregnant 
women. These activating autoantibodies to the angiotensin type 1 
receptor have been shown in an animal model to result in enhanced 
sensitivity to angiotensin [17]. Infusion of AT1-AA resulted in an 
exaggerated response to angiotensin II, a phenomenon which is known 
to occur in women with preeclampsia, the mechanism by which was 
previously unexplained. Further, chronic infusion of the AT1-AA has 
also been shown to increase production of sFlt-1 and soluble endoglin, 
activation of the ET-1 pathway and placental oxidative stress, all of 
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Similar to preeclamptic women, hypertension in the chronic Reduced Uterine Perfusion Pressure Rat Model Of 
Preeclampsia (RUPP) is associated with increased CD4+ T cells, cytokines, sFlt-1 and agonistic autoantibodies to 
the AngII receptor (AT1-AA). We examined the effect inhibition of T cell co-stimulation in RUPP rats treated with (A) 
(abatacept, 250 mg/kg, infused i.v. at gestation day 13), on hypertension and sFlt-1, TNF-α and AT1-AA. RUPP surgical 
procedure was performed on day 14. On day 19 MAP increased from 94+2 mmHg in Normal Pregnant (NP) to 123 ± 3 
mmHg in RUPP control rats. This response was attenuated by Abatacept, MAP was 104 ± 2 mmHg in RUPP ± A, and 
96 ± 2 mmHg NP ± A. Percent circulating CD4+ T cells were 66 ± 3% in RUPPs compared to 55 ± 3% NP rats (p<0.04) 
but were normalized in RUPP ± A rats (54 ± 3%). The twofold increase in TNF alpha seen in RUPPs (277 ± 47 pg/ml) 
was decreased to 80 ± 18 pg/ml in RUPP+A. Placental sFlt-1 was reduced 70 % to 151 ± 28 in RUPP ± A compared 488 
± 61 pg/ml in RUPP (p<0.001). AT1-AA decreased from 20 ± 0.8 bpm in control RUPP to 6 ± 0.7 bpm in RUPP ± A. We 
next determined the effect of RUPP in causing hypertension in pregnant T cell deficient rats by examining MAP in NP 
(123 ± 5 mmHg) and RUPP athymic nude rats (123 ± 7 mmHg). In the absence of T cells, hypertension in response to 
placental ischemia was completely abolished. Collectively these data indicate that CD4+ Tcells in response to placental 
ischemia play an important role in the pathophysiology of hypertension associated with preeclampsia.
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which are important players in the pathophysiology of preeclampsia 
[10-13,16,17,21,22]. 
We have recently demonstrated that magnetically separated and 
cultured CD4+ T cells from RUPP rats secrete greater amounts of TNF 
alpha, IL-6, IL-17 and sFlt-1 into their cell culture media compared 
to NP CD4+ T cells [23]. Further, adoptive transfer of CD4+ Tcells 
from RUPP dams into NP dams results in increased blood pressure 
and elevations in many factors shown to be stimulated by placental 
ischemia in the RUPP rat, such as sFlt-1, ET-1, TNF alpha, IL-6 and 
AT1-AA [11,23]. However a role for endogenous T cells to mediate 
secretion of such factors and hypertension in response to placental 
ischemia remained unidentified. Therefore the objective of the current 
study was to determine the effects of inhibiting endogenous Tcell co-
stimulation prior to placental injury on blood pressure and placental 
ischemia stimulated soluble factors. Two approaches were taken 
to answer this question. First, abatacept (Orencia) which is a fusion 
molecule of CTLA 4 designed to inhibit co-stimulation of T cells in 
response to antigens, was administered to pregnant rats on gestational 
day 13, RUPP was induced on day 14 and blood pressure and soluble 
factors were collected on day 19. Inhibition of T cell co-stimulation 
has proven efficient in other animal models of autoimmune disease 
and is now being used clinically to treat patients in various chronic 
inflammatory states such as hepatits B and rheumatoid arthritis [5,6]. 
A second approach was to examine the hypertensive effect of RUPP on 
athymic nude T cell deficient pregnant rats. 
Materials and Methods
All animal studies were performed in timed pregnant Sprague 
Dawley rats or Athymic Nude virgin or pregnant rats purchased from 
Harlan Inc (Indianapolis, IN). Animals were housed in a temperature 
controlled room (23°C) with a 12:12 light:dark cycle. Athymic nude rats 
were housed in an isolated barrier temperature controlled room (23°C) 
with a 12:12 light:dark cycle. All experimental procedures executed 
in this study were in accordance with the NIH guidelines for the use 
and care of animals. All protocols were approved by the Institutional 
Animal Care and Use Committee (IACUC) and the University of 
Mississippi Medical Center.
Inhibition of T cell co-stimulation in the Reduced Uterine 
Perfusion Pressure (RUPP) rat model of preeclampsia
To determine the role of endogenous T cells in mediating 
hypertension in RUPP rats, four groups of pregnant rats were 
examined: normal pregnant (NP, n=20), Reduced uterine perfusion 
pressure (RUPP, n=20), NP + Orencia (Abatacept) (NP+A; n=12) and 
RUPP + Orencia (Abatacept) (RUPP ± A; n=19). Orencia, Abatacept, 
(250mg/kg) was infused IV via jugular catheter over a 20 minute 
period on day 13 to NP (n=31) rats, 19 of which underwent the RUPP 
surgical procedure on day 14, same day as RUPP controls. The RUPP 
procedure reduces the uterine perfusion pressure with the application 
of a constrictive silver clip (0.203 mm) to the aorta superior to the iliac 
bifurcation performed via a midline laparotomy. Ovarian collateral 
circulation to the uterus is reduced with restrictive clips (0.100 mm) 
to the bilateral uterine arcades at the ovarian end. Under isoflourane 
anesthesia restrictive clips are implanted on day 14 of gestation. On 
day 18 of gestation carotid arterial catheters were inserted for blood 
pressure measurements. The catheters inserted are V3 tubing (SCI) 
which is tunneled to the back of the neck and exteriorized. On day 19 
of gestation arterial blood pressure was analyzed after placing the rats 
in individual restraining cages. Arterial pressure was monitored with 
a pressure transducer (Cobe III Transducer CDX Sema) and recorded 
continuously after a one hour stabilization period. Serum, plasma, 
and tissues were collected under isoflourane anesthesia on day 19 of 
gestation for molecular analysis. Plasma and serum were stored at 
-20°C and tissues at -80°C.
Determination of circulating T lymphocytes in response to 
Orencia (Abatacept) administration 
Total populations of circulating CD4+ and CD8+ T cells were 
measured from peripheral blood leukocytes (PBL) collected at 
day 19 of gestation from pregnant RUPP rats with and without 
administration of Abatacept. We utilized flow cytometry analysis to 
detect percent circulating CD4+ and CD8+ T cell populations isolated 
from RUPP and NP rat PBLs. At the time of tissue harvest, plasma 
was collected and PBLs were isolated from plasma by centrifugation 
on a cushion of Ficoll-Hypaque (Lymphoprep, Accurate Chemical 
Corp) according to the manufacturer’s directions. For flow cytometric 
analysis equal numbers of leukocytes (1 × 106) were incubated for 30 
minutes at  4°C with antibodies against mouse CD4 and mouse CD8 
(BD Biosciences, San Jose, CA). After washing, cells were labeled with 
the secondary Fluorescein Isothiocyanate (FITC) Phycoerythrin (PE) 
antibodies (Southern Biotech, Birmingham, AL) for 30 minutes at 4°C. 
As a negative control, for each individual rat, cells were treated exactly 
as described above except they were incubated with anti-FITC and 
anti-PE secondary antibodies alone. Subsequently, cells were washed 
and suspended in 500 µl of Roswell Park Memorial Institute medium 
(RPMI) and analyzed for single staining on a Gallios flow cytometer 
(Beckman Coulter, Brea, CA). The percent of positive staining cells 
above the negative control was collected for each individual rat and 
mean values for each experimental group (RUPP and RUPP + A) was 
calculated.
Determination of AT1-AA production in response to 
blockade of CD4+ T cells prior to placental ischemic insult
Antibodies were detected by the chronotropic responses to AT1 
receptor–mediated stimulation of cultured neonatal rat cardiomyocytes 
coupled with receptor-specific antagonists as previously described 
[10-13,16,17]. Briefly, on day 18 of gestation blood was collected and 
immunoglobulin was isolated from one ml of serum by specific anti-rat 
IgG column purification. Subsequently, AT1-AA was purified by the 7 
amino acid epitope binding from the column purified rat IgG. AT1-AA 
activity was measured, as previously described, utilizing a bioassay that 
we have previously published in which the chronotropic response of rat 
neonatal cardiomyocytes in culture is detected and counted. Increased 
chronotropic response is counted and expressed as the change in beats/
minute (∆bpm) of the rat neonatal cardiomyocytes in culture, therefore 
units of AT1-AA are expressed as ∆bpm over basal levels. 
TNF-α in response to inhibition of T cell co-stimulation prior 
to placental ischemic insult
A rat TNF-α colorimetric sandwich ELISA (R&D Systems) was 
used for quantification of serum TNF-α levels between 12.5 and 800 
pg/ml. This assay displayed a sensitivity level of 5 pg/ml and interassay 
variability of 10% and intra-assay variability of 5.1%. 
Placental sFlt-1 in response to inhibition of T cell co-
stimulation prior to placental ischemic insult
We have shown that placental explants from RUPP rats or AT1-
AA infused rats displayed increased placental production of sFlt-
1. Further we demonstrated that RUPP CD4+ Tcells secrete sFlt-1 
in vitro and stimulate sFlt-1 elevation in NP recipient rats of RUPP 
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CD4+ T cells. Therefore, we hypothesized that production of sFlt-1 
would be attenuated by suppressing T cells in RUPP rats treated with 
Abatacept prior to the placental ischemic insult (described above). 
Freshly harvested placentas collected from four control RUPPs and 
six RUPP+A rats were rinsed in cold phosphate buffered saline and 
the myometrium layer was isolated from the decidua and the vascular 
bundle was excised. Villous explants were plated on matrigel 6-well 
cell culture filter inserts and cultured in Dulbecco’s modified Eagle 
medium/F12 supplemented with 0.25  µg/ml ascorbate and 10U 
Pen/Strep at 37°C, 6% O2, 89% N2, 5% CO2 conditions [13]. Culture 
media was analyzed for sFlt-1 secretion via ELISA, Murine vascular 
endothelial growth factor R1 enzyme-linked immunosorbent assay 
from R&D Systems. The variability for intra-assay was 7.2% and 
interassay was 8.4%.
Uterine artery resistive index in response to inhibition of T 
cell co-stimulation prior to placental ischemic insult
In a method described by Tam Tam [24] Power Doppler 
velocimetry measurements were performed on anesthetized pregnant 
dams at an imaging station with a Vevo 770 unit (Visual sonics) using a 
30 Hz transducer and an insonating angle <30°. The Peak Systolic flow 
Velocity (PSV) and End Diastolic flow Velocity (EDV) were recorded 
using the uterine artery Doppler waveform. The uterine artery resistive 
index was calculated using the following formula: UARI= (PSV-EDV)/
PSV. Uterine artery resistive index was determined for the uterine 
artery bilaterally at three levels and the mean was calculated for control 
RUPPs and compared to RUPPs + A. 
Statistical analysis
All data are expressed as mean ± standard error. Differences 
between control and experimental groups were analyzed using the 
Student’s t-test for renal function. Blood pressure analysis and AT1-
AA levels were analyzed using 1 way ANOVA for comparison among 
multiple groups. Values were of p<0.05 were considered significant.
Results
Effect of inhibition of T cell stimulation prior to placental 
ischemic insult on blood pressure, AT1-AA, TNF alpha, 
placental sFlt-1 and uterine artery resistive index
Percent circulating CD4+ T cells increased in RUPPs compared to 
NP rats, 66 ± 3% and 55.5+2.7% respectively (p<0.04). Administration 
of Abatacept attenuated the rise in circulating T cells in RUPP rats 
compared to RUPP controls. Circulating CD4+ Tcells were normalized 
to 54.8 ± 2.5% in RUPP+A rats. Abatacept had no effect of circulating 
CD4+ Tcells in NP rats, CD4+ T cells were 59 ± 4% in NP+A (Figure 1). 
CD8+ T cells are not significantly different from NP to RUPP control 
rats (24 ± 4% to 29 ± 5%). Administration of abatacept had no effect to 
decrease CD8+ T cells in either NP (25 ± 5%) or RUPP rats (25 ± 5%) 
illustrating the specificity and efficiency of abatacept on CD4+ T cells 
(Figure 1). 
MAP increased from 94 ± 2 mmHg in NP rats to 123 ± 3 mmHg in 
RUPP rats. This hypertensive response was attenuated with inhibition 
of CD4+ T cell stimulation in RUPP rats. MAP was 96 ± 2 mmHg in 
NP+A, and only increased 8 mmHg to 104 ± 2 mmHg in RUPP+A 
(Figure 2). Pup weights were significantly decreased in RUPP rats 
compared to NP rats (1.97 ± 0.05 vs 2.24 ± 0.05 grams) and decreased 
further to1.8 ± 0.04 grams in RUPP+A but were unchanged in NP + 
A (2.13 ± 0.04grams). No other morphological changes were noted in 
pups of RUPP rats treated with Abatacept. 
Placental ischemia significantly increased AT1-AA production 
in RUPP compared to NP controls, as measured by an increase in 
cardiomyocyte chronotropic events expressed as beats per minute 
(bpm). NP rats display a 1.3 ± 0.6 bpm in cardiomyocyte chronotropic 
events while RUPP rats have significantly higher levels of 20 ± 0.41 bpm 
in cardiomyocyte chronotropic events. No change in cardiomyocyte 
chronotropic events were seen in NP rats treated with Abatacept 
(NP+A 0.67 ± 0.47 bpm). However, in stark contrast, inhibition of 
CD4+ Tcell co-stimulation had a significant effect to decrease AT1-AA 
production in RUPP rats treated with Orencia, RUPP+A displayed 6.4 
± 0.755 bpm (Figure 3). 
Administration of Abatacept significantly 
decreased circulating CD4+ T cells in RUPP rats
(% gated)
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Figure 1: Administration of Abatecept significantly decreased circulating 
CD4+ T cells in RUPP rats. As previously shown circulating CD4+ T cells 
are increased in RUPP rats compared to NP rats. There is no difference in 
circulating CD8+T cells. This figures illustrates that with IV administration of 
orencia circulating T cells are normalized (P<0.0018) compared to RUPP rats.
Inhibition of T cell stimulation blunts the blood pressure 
response to placental ischemia during pregnancy
MAP
(mmHg)
* P= 0.01 vs NP
* P= 0.01 vs RUPP 
NP RUPP NP+A RUPP+A
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Figure 2: Inhibition CD4+ Tcell co-stimulation blunts the blood pressure 
response to placental ischemia during pregnancy. As previously shown, 
blood pressure increases in RUPP rats, approximately 25 mmHg (P<0.01). 
Inhibition of T cell co-stimulation ultimately leads to suppressed blood pressure 
response to placental ischemia. RUPPs treated with Abatecept displayed 
an 8 mmHg increase in blood pressure compared to NP rats treated with 
Abatecept. This difference what not statically significant. However, RUPP+ 
Ado display significantly less blood pressure increase than control RUPPs 
(P<0.01). Pup weight is consistently decreased in RUPP rats compared to 
NP rats, however, pup weight was not improved with T cell blockade in RUPP 
rats.
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The two fold increase in circulating TNF alpha characteristically 
seen in RUPP rats (277 ± 47 pg/ml) was significantly decreased to 80 
± 18 pg/ml in RUPPs+A. Placental explant secretion of sFlt-1 at 2 hrs 
of culture was 186 ± 60 in RUPPs, but was decreased to 53 ± 7 pg/
ml in RUPP rats treated with Abatacept. Placental explant secretion of 
sFlt-1 at 24 hrs culture was 488 ± 61 pg/ml in RUPP placentas but was 
significantly decreased to 151 ± 28 pg/ml in placentas from RUPP+A 
rats (p<0.001) (Figure 4). Uterine artery resistive index increased 
from 0.6 ± 0.02 in NP dams to 0.68 ± 0.02 in RUPP dams. Blockade of 
CD4+ T cells normalized uterine artery resistive index to 0.61 ± 0.03 in 
RUPP+A pregnant rats.
Effect of RUPP on athymic nude pregnant rats
Virgin and normal pregnant athymic nude rats were obtained from 
Harlan. Four underwent the RUPP procedure on day 14 of gestation 
and four were utilized as controls. Inducing placental ischemia in 
CD4+ T cell deficient pregnant rats had no effect to increase blood 
pressure during pregnancy. MAP in control athymic nude rats was 114 
± 5 mmHg. MAP in control athymic nude pregnant rats was 123 ± 5 
mmHg. MAP in RUPP athymic nude rats was 123 ± 7 mmHg (Figure 
5). 
Discussion
While the immunologic profiles of preeclamptic women have been 
well described, the stimulus for the immunologic shift that occurs 
between a normal and preeclamptic pregnancy is not understood 
[3,7,15,18-20,23]. Previous work has demonstrated that both TNF-α 
and the AT1-AA can serve to stimulate the production of sFlt-1 from 
the placenta during pregnancy [12]. Our previous adoptive transfer 
data shows that CD4+ T cells stimulated in response to placental 
ischemia can induce a preeclamptic like state in a normal pregnant rat 
without any additional stimulus [11,23].
It was also demonstrated that adoptive transfer of placental 
ischemic stimulated CD4+ Tcells were responsible for alterations in 
renal hemodynamics [11]. As previously described by Alexander et al. 
in 2001 [25], reduction in uterine perfusion pressure during pregnancy 
is associated with decreased glomerular filtration rate, increased renal 
vascular resistance, and decreased renal perfusion flow. This profile of 
altered renal hemodynamics was similar to the profile attained with 
exposure to placental ischemic stimulated CD4+ T cells without any 
mechanical reduction in uterine perfusion [11]. This suggests that it is 
not the actual mechanical decrease in blood flow that leads to the altered 
renal hemodynamics, but rather, the immunologic response to that 
stimulus. It is likely that these findings also suggest that while immune 
activation plays a large role in the alteration of renal hemodynamics, it 
is just one of a myriad of stimuli working together in vivo to create the 
preeclamptic phenotype.
The hypertensive response to RUPP CD4+ T Lymphocytes was 
attenuated by AT1 receptor blockade with Losartan [11]. It is not clear 
whether the reduction in MAP was due to blockade of the AT1-AA 
or blockade of endogenous AngII activation of AT1 receptor. This 
question was answered with B cell depletion with Rituximab. Once 
the CD20 costimulating molecule is blocked, endogenous B cells are 
AT1-AA
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* P= 0.05 vs RUPP 
Inhibition of T cell stimulation attenuates 
production of AT1-AA in response to placental 
ischemia
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0
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NP RUPP              NP+A RUPP+A
Figure 3: Inhibition of T cell co-stimulation attenuates production of AT1-AA 
in response to placental ischemia during pregnancy. We have consistently 
demonstrated AT1-AA produced in response to placental ischemia. With T 
cell suppression, AT1-AA is significantly lowered in RUPP+A compared to 
control RUPPS (P<0.05).
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Figure 4: Inhibition of T cell co-stimulation attenuates production of TNF-α 
and placental sFlt-1 in RUPP pregnant rats. Placental ischemia stimulates 
TNF alpha and placental sFlt-1. Administration of Abatecept and suppression 
of T cells decreased circulating TNF alpha and placental secreted sFlt-1 in 
RUPP+ A compared to RUPP control rats.
CD4+ T cells play a critical role in mediating 
hypertension in response to placental ischemia
MAP
(mmHg)
Normal Pregnant    RUPP
Athymic Nude pregnant rats
50
70
90
110
130
150
Athymic Nude virgin rats
Figure 5: T cells play a critical role in mediating hypertension in response to 
placental ischemia. Inducing placental ischemia in pregnant rats deficient in T 
cells had no effect to increase blood pressure during pregnancy. Both NP and 
RUPP in athymic/nude rats had blood pressures of 123 mmHg. 
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not stimulated to produce antibodies. By treating NP+RUPP CD4+T 
cell injected rats with Rituximab, AT1-AA levels were significantly 
suppress and MAP was decreased to NP levels [11].
Because B cell depletion with an anti-CD20 compound has 
been demonstrated to decrease production of the AT1-AA during 
pregnancy in response to surgical placental ischemia [13], and it was 
demonstrated in this data that MAP in response to adoptive transfer 
of ischemic stimulated CD4+ Tcells was reduced with the same 
compound, these findings posed the question whether blockade of the 
interaction between the antigen presenting cell and the T cell could 
have the same results. CTLA-4, homologous to CD28, is expressed 
on activated T cells and binds to its ligand B7 as an important co-
stimulatory signal to T cells [26]. Orencia (Abatacept) is a CTLA-4 
immunoglobulin used experimentally to inhibit the T cell immune 
response by blocking this interaction. In this study, treatment of RUPP 
rats with Orencia (abatacept) prior to the placental insult was shown to 
significantly decrease MAP when compared to untreated RUPP rats. 
The reduction in MAP occurs in parallel with a significant reduction 
in AT1-AA from treated RUPP rats (Figure 2 and 3). This reduction in 
MAP, and suppression of AT1-AA production, was further explained 
by examining the absolute percentage of T cells in each group. The 
RUPP+A rats had circulating CD4+ T cell levels more similar to NP 
than RUPP rats (Figure 1). Further examination of the effect of CD4+ 
T cell blockade demonstrated that increased secretion of TNF-α 
and placental sFlt-1 in response to RUPP in pregnant rats were also 
significantly reduced. We have previously published that the RUPP rat 
model of PE has increased circulating TNF-α and placental secretion 
of the anti-angiogenic factor sFlt-1(Figure 4) [6-13,23,24]. We have 
previously shown that RUPP CD4+ Tcells are important sources of 
these factors. In this study we demonstrate the importance of T cells 
to be associated with increased secretion of these factors in response 
to placental ischemia by demonstrating that inhibition of CD4+ T cell 
stimulation prevents elevations in TNF alpha and placental sFlt-1 in 
association with hypertension in response to placental ischemia. 
Additionally, we have shown that RUPP rats display a significant rise 
in uterine artery resistive index [24]. In 2011, Tam Tam, demonstrated 
similar findings in reductions in uterine artery resistive index in RUPP 
rats treated with an endothelin antagonist. The significant increase 
in uterine artery resistive seen in rats having undergone the RUPP 
procedure was also attenuated in the group of RUPP rats treated 
with Abatacept. These findings are similar to the renal hemodynamic 
findings, in that although it seems as though alterations in blood flow 
with RUPP are largely due to the mechanical obstruction caused by 
the RUPP procedure, there is an additional component stimulated 
by the response to placental ischemia that acts in concert to mediate 
the other pathophysiological components in RUPP rats that are seen 
in preeclamptic women. Interestingly, pup weights of RUPPs+A 
were less than the control RUPPs (Figure 2). However, no other fetal 
abnormalities were noted nor reductions in litter sizes were noted. 
To further illustrate the importance of T cells in mediating 
hypertension in response to placental ischemia, we performed the 
RUPP procedure in athymic/nude pregnant rats, rats deficient in 
T cells. We demonstrate a lack of blood pressure response in RUPP 
athymic/nude pregnant rats, thereby confirming our hypothesis that 
T cells are important to cause hypertension in response to placental 
ischemia (Figure 5). 
These findings lend hope that one day there will be an acceptable 
treatment for preeclampsia. While no current treatments are able to 
modify the failed trophoblastic invasion of the uterine spiral arterioles, 
these findings in the RUPP model show that although surgically 
reduced uterine perfusion is present, the effects of preeclampsia with 
respect to T helper cells, MAP, AT1-AA production, and cytokine 
profiles can be pharmacologically improved to mimic normal pregnant 
levels and thus lead to a more normal pregnancy.
Perspectives and Significance
It has been demonstrated that CD4+ T cells in response to 
placental ischemia are responsible for hypertension, alterations in 
renal hemodynamics, production of inflammatory cytokines and 
anti-angiogenic molecules, as well as stimulating the production 
of agonistic autoantibodies to the angiotensin type I receptor. The 
effects of placental ischemia on blood pressure and many facets seen 
in preeclampsia can be attenuated with inhibition of T cells either by 
blockade of antigen presenting cells interacting with T cells or by overall 
T cell deficiency. Importantly, these data suggests the potential use of 
anti- inflammatories targeting T cell suppression as a therapeutic for 
preeclampsia. These studies highlight the importance of targeting CD4+ 
T cell suppression as an avenue to decrease blood pressure, cytokine 
production, anti-angiogenic factors, autoantibodies and uterine artery 
resistive index to improve preeclampsia symptoms late in pregnancy in 
PE women. Targeting the overactive immune system late in pregnancy 
in PE women could be a safe and potential therapeutic to improve 
pregnancy outcomes in women with this disease.
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